RNU4ATAC11P

Across TCGA pan-cancer cohorts, RNU4ATAC11P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RNU4ATAC11P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU4ATAC11P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU4ATAC11P is over-expressed in tumor.

STAD are the cancer types where RNU4ATAC11P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU4ATAC11P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	III,IV	+0.816	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

RNU4ATAC11P–STAD

Open the STAD breakdown →